Continuous Glucose Monitor for Mayo Clinic Advanced Care at Home Patients
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05880810
- Status
- Recruiting
Conditions
- Diabetes Mellitus
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Continuous Glucose Monitor Dexcom G6 PRO — DEVICEConnected to a smart phone that transmits continuous glucose monitoring data in real time to Advanced Care at Home Command Center for monitoring.
Study Details
The purpose of this study is to measure differences in diabetes control with the use of continuous glucose monitor (CGM) and diabetes education compared with standard of care for glucose monitoring (glucometer checks) and diabetes education in participants with diabetes mellitus receiving therapy with insulin and being admitted to Mayo Clinic Advanced Care at Home Program (ACH).
Key Dates
- Start date
- May 1, 2024
- Status verified
- Jun 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Continuous Glucose MonitoringSubjects admitted to the Advanced Care at Home program (home hospital) will have the continuous glucose monitor sensor placed for up to 10 days to monitor and dose insulin.
- No Intervention: Control Arm (Standard of Care)Subjects admitted to the Advanced Care at Home program (home hospital) will continue with standard of care glucose monitoring (capillary glucose levels checked via glucometer), insulin dosing, and DM treatment during the 10 day period.
Primary Outcome Measure
Time in Range [ Time Frame: 10 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Florida | Jacksonville | Florida | 32224 |
Find similar trials in Jacksonville, FL
By research site
Related Studies
- A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot UlcerPHASE3 · Recruiting · Energenesis Biomedical Co., Ltd. · Miami, Florida
- Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral NeuropathyRecruiting · Florida Institute for Human and Machine Cognition · Pensacola, Florida
- Prolongation of GLP-1 Adherence When Using Continuous Glucose MonitoringRecruiting · Abbott Diabetes Care · Jacksonville, Florida
- SPYRAL GEMINI Pilot StudyRecruiting · Medtronic Vascular · Stanford, California